Altimmune Inc.

NASDAQ: ALT · Real-Time Price · USD
3.55
-0.08 (-2.20%)
At close: Aug 18, 2025, 3:59 PM
3.58
0.77%
After-hours: Aug 18, 2025, 04:21 PM EDT

Altimmune Revenue

Altimmune reported an annual revenue of $20K, reflecting a -95.31% growth. For the quarter ending June 30, 2025, Altimmune generated $5K in revenue.
Revenue (ttm)
20K
Revenue Growth
-95.31%
Price / Sales Ratio
25596.73
Revenue / Employee
338.98
Employees
59
Market Cap
313.53M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 20K -95.31%
Dec 31, 2023 426K +-726.47%
Dec 31, 2022 -68K -101.54%
Dec 31, 2021 4.41M -46.12%
Dec 31, 2020 8.19M +41.09%
Dec 31, 2019 5.8M -43.85%
Dec 31, 2018 10.33M +24792.58%
Dec 31, 2017 41.5K -99.21%
Dec 31, 2016 5.23M -50.85%
Dec 31, 2015 10.64M +4.42%
Dec 31, 2014 10.19M -43.11%
Dec 31, 2013 17.91M -28.85%
Dec 31, 2012 25.18M +3.75%
Dec 31, 2011 24.27M +15.59%
Dec 31, 2010 20.99M -23.80%
Dec 31, 2009 27.55M -16.29%
Dec 31, 2008 32.91M +124.75%
Dec 31, 2007 14.64M +692.53%
Dec 31, 2006 1.85M +215.27%
Dec 31, 2005 586.07K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.